- New Australian research suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may not increase vaccine efficacy against SARS-CoV-2.
- The results suggest one dose of the vaccine could be sufficient in providing a robust immune response 11 days after inoculation.
- The findings could help shape policy as vaccine rollout has been slow in countries such as the United States and Canada.
A team of researchers suggests that one dose of the Pfizer-BioNTech vaccine could be sufficient in...
https://mfame.guru/pfizer-vaccine-effective-from-day-11-post-1st-dose-study-finds/